These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 4137120)

  • 21. Factor XI: purification from porcine plasma by affinity chromatography and some properties of factor XI and activated factor XI.
    Mashiko H; Takahashi H
    Biol Chem Hoppe Seyler; 1994 Jul; 375(7):481-4. PubMed ID: 7945997
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Studies on the product of the reaction between activated Hageman factor (factor XII) and plasma thromboplastin antecedent (factor XI).
    Ratnoff OD
    J Lab Clin Med; 1972 Nov; 80(5):704-10. PubMed ID: 4673237
    [No Abstract]   [Full Text] [Related]  

  • 23. Identification of a defective factor XI cross-reacting material in a factor XI-deficient patient.
    Mannhalter C; Hellstern P; Deutsch E
    Blood; 1987 Jul; 70(1):31-7. PubMed ID: 2439152
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of collagen on fibrinolysis.
    Engel AM; Alexander B
    Thromb Diath Haemorrh Suppl; 1973; 56():63-74. PubMed ID: 4376277
    [No Abstract]   [Full Text] [Related]  

  • 25. Intravenous administration of plasmin treated immunoglobulins in 10 patients with agammaglobulinemia.
    Luzi G; Bonomo R; Frielingsdorf A; Palmisano L; Zolla S; Seminara R; Fiorilli M; Barbato M; Aiuti F
    Ann Sclavo; 1981; 23(4):413-20. PubMed ID: 6179481
    [No Abstract]   [Full Text] [Related]  

  • 26. THE INDUCTION OF PERMEABILITY-INCREASING ACTIVITY IN HUMAN PLASMA BY ACTIVATED HAGEMAN FACTOR.
    RATNOFF OD; MILES AA
    Br J Exp Pathol; 1964 Jun; 45(3):328-45. PubMed ID: 14173175
    [No Abstract]   [Full Text] [Related]  

  • 27. [Serum levels of immunoglobulins, albumins and beta-1 c-1A-globulins in patients with liver diseases].
    Aigner A; Gabl F; Knapp E
    Wien Klin Wochenschr; 1971 Sep; 83(36):637-40. PubMed ID: 4105863
    [No Abstract]   [Full Text] [Related]  

  • 28. Partial purification and characterization of contact activation cofactor.
    Schiffman S; Lee P
    J Clin Invest; 1975 Nov; 56(5):1082-92. PubMed ID: 1184736
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Surface activation of blood coagulation, fibrinolysis and kinin formation.
    Heimark RL; Kurachi K; Fujikawa K; Davie EW
    Nature; 1980 Jul; 286(5772):456-60. PubMed ID: 6447254
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasmin-mediated activation of contact system in response to pharmacological thrombolysis.
    Ewald GA; Eisenberg PR
    Circulation; 1995 Jan; 91(1):28-36. PubMed ID: 7805216
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Change in plasma esterase activity during stimulation of the "2d anticoagulation system"].
    Baskova IP; Cherkesova DU; Orlova AS; Kudriashov BA
    Vopr Med Khim; 1974; 20(5):482-9. PubMed ID: 4456798
    [No Abstract]   [Full Text] [Related]  

  • 32. [Immunological phenomenon in experimental toxoplasmosis. II. Qualitative and quantitative kinetic development of serum constituents in CBA mice].
    Tailliez R; Floc'h F; Vernes A; Biguet J
    Ann Parasitol Hum Comp; 1974; 49(3):291-300. PubMed ID: 4140704
    [No Abstract]   [Full Text] [Related]  

  • 33. Intrinsic activation of prothrombin potentiated by celite and reduced by kaolin.
    Kang EP; Triantaphyllopoulos DC
    Thromb Diath Haemorrh; 1974 Dec; 32(2-3):600-7. PubMed ID: 4375311
    [No Abstract]   [Full Text] [Related]  

  • 34. Activation of rabbit Hageman factor by homogenates of cultured rabbit endothelial cells.
    Wiggins RC; Loskutoff DJ; Cochrane CG; Griffin JH; Edgington TS
    J Clin Invest; 1980 Jan; 65(1):197-206. PubMed ID: 6444222
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cleavage of human high molecular weight kininogen markedly enhances its coagulant activity. Evidence that this molecule exists as a procofactor.
    Scott CF; Silver LD; Schapira M; Colman RW
    J Clin Invest; 1984 Apr; 73(4):954-62. PubMed ID: 6561202
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ANTIHEPARIN ACTIVITY OF SOME HUMAN BLOOD PROTEIN FRACTIONS AND THEIR POSSIBLE RELATIONSHIP TO THROMBOSIS.
    DEWHURST F; POLLER L
    J Clin Pathol; 1965 May; 18(3):339-44. PubMed ID: 14304249
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunochemical studies of plasma kallikrein.
    Bagdasarian A; Lahiri B; Talamo RC; Wong P; Colman RW
    J Clin Invest; 1974 Dec; 54(6):1444-54. PubMed ID: 4140197
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Origin of the high molecular weight activator of prekallikrein.
    Bagdasarian A; Lahiri B; Colman RW
    J Biol Chem; 1973 Nov; 248(22):7742-7. PubMed ID: 4127217
    [No Abstract]   [Full Text] [Related]  

  • 39. Studies on protein fractions isolated from human plasma. Kininogenase activity in human plasma fractions isolated with ether and ethanol.
    Mackay M; Silk E; Mason B; Combridge BS
    Br J Haematol; 1970 Jan; 18(1):29-44. PubMed ID: 4244533
    [No Abstract]   [Full Text] [Related]  

  • 40. An informatic analysis of serum protein disturbances in clinical pathology.
    Sandor G; Diday E; Lechevallier Y; Barré J
    Ann Immunol Hung; 1972; 16(0):383-408. PubMed ID: 4137537
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.